Egalet Corp Business Finance Contracts & Agreements

35 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Zyla Life Sciences Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Egalet Corp
Pharmaceuticals
2020
Amendment No. 3 to Asset Purchase Agreement, dated as of May 31, 2019
Purchase Agreements
Egalet Corp
Pharmaceuticals
2019
Egalet Corporation Form of Non-Qualified Stock Option Agreement
Stock Agreements
Egalet Corp
Pharmaceuticals
DE
2019
Form of Certificate of Common Stock
Stock Agreements
Egalet Corp
Pharmaceuticals
2019
Third Amendment to Forbearance Agreement among Egalet Corporation, Guarantors, and Supporting Holders of 13% Senior Secured Notes
Forbearance Agreements
Egalet Corp
Pharmaceuticals
2018
Amendment to Forbearance Agreement between Egalet Corporation, Guarantors, and Supporting Holders of 13% Senior Secured Notes
Forbearance Agreements
Egalet Corp
Pharmaceuticals
2018
Amendment to Forbearance Agreement between Egalet Corporation, Guarantors, and Supporting Holders of 13% Senior Secured Notes
Forbearance Agreements
Egalet Corp
Pharmaceuticals
2018
Forbearance Agreement among Egalet Corporation, Guarantors, and Supporting Holders of 13% Senior Secured Notes
Forbearance Agreements
Egalet Corp
Pharmaceuticals
NY
2018
Egalet Corporation Restricted Stock Award Agreement with Grantee under 2013 Stock-Based Incentive Compensation Plan
Equity Distribution Agreements
Egalet Corp
Pharmaceuticals
DE
2018
Egalet Corporation Stock Option Agreement with Participant under 2013 Incentive Plan
Warrant Agreements
Egalet Corp
Pharmaceuticals
DE
2017
Common Stock Purchase Warrant Agreement between Egalet Corporation and Holder (July 2017)
Warrant Agreements
Egalet Corp
Pharmaceuticals
2017
Egalet Corporation Underwriting Agreement with Cantor Fitzgerald & Co. for Common Stock and Warrants (July 6, 2017)
Underwriting Agreements
Egalet Corp
Pharmaceuticals
2017
Egalet Corporation Option Agreement under 2017 Inducement Plan
Warrant Agreements
Egalet Corp
Pharmaceuticals
DE
2017
Royalty Right Agreement between Egalet Corporation and Purchaser (January 18, 2017)
Purchase Agreements
Egalet Corp
Pharmaceuticals
DE
2017
Amendment No. 3 to Loan and Security Agreement among Egalet Corporation, Hercules Technology Growth Capital, Inc., and Hercules Funding II, LLC
Loan Agreements
Egalet Corp
Pharmaceuticals
2015
Egalet Corporation Underwriting Agreement with Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC (July 28, 2015)
Underwriting Agreements
Egalet Corp
Pharmaceuticals
2015
Waiver and Amendment Agreement to Loan and Security Agreement between Egalet Corporation and Hercules Technology Growth Capital, Inc.
Waiver Agreements
Egalet Corp
Pharmaceuticals
NY
2015
Amendment No. 2 to Loan and Security Agreement among Egalet Corporation, Egalet US Inc., and Hercules Technology Growth Capital, Inc.
Loan Agreements
Egalet Corp
Pharmaceuticals
2015
Amendment No. 1 to Loan and Security Agreement by and among Egalet Corporation, Hercules Technology Growth Capital, Inc., and Lenders
Loan Agreements
Egalet Corp
Pharmaceuticals
2015
Loan and Security Agreement between Egalet Corporation and Hercules Technology Growth Capital, Inc. dated January 7, 2015
Loan Agreements
Egalet Corp
Pharmaceuticals
NY
2015
Warrant Agreement to Purchase Common Stock of Egalet Corporation by Hercules Technology Growth Capital, Inc. (January 7, 2015)
Warrant Agreements
Egalet Corp
Pharmaceuticals
NY
2015
Egalet Corporation Non-Qualified Stock Option Agreement with Participant
Warrant Agreements
Egalet Corp
Pharmaceuticals
DE
2014
Egalet Corporation Common Stock Underwriting Agreement with Stifel, Nicolaus & Company, Incorporated and JMP Securities LLC
Underwriting Agreements
Egalet Corp
Pharmaceuticals
2014
Waiver Agreement to Indenture for Egalet Corporation 6.50% Convertible Senior Notes Due 2024
Waiver Agreements
Egalet Corp
Pharmaceuticals
2018
Indenture for 6.50% Convertible Senior Notes due 2024 between Egalet Corporation, Guarantors, and The Bank of New York Mellon
Indenture Agreements
Egalet Corp
Pharmaceuticals
NY
2017
Exchange Agreement between Egalet Corporation, Guarantors, and Noteholders (December 20, 2017)
Exchange Agreements
Egalet Corp
Pharmaceuticals
NY
2017
Exchange Agreement between Egalet Corporation, Guarantors, and Noteholders for Convertible Senior Notes
Exchange Agreements
Egalet Corp
Pharmaceuticals
NY
2017
Egalet Corporation Restricted Stock Award Agreement with Grantee under 2013 Stock-Based Incentive Compensation Plan
Equity Distribution Agreements
Egalet Corp
Pharmaceuticals
DE
2016
Registration Rights Agreement between Egalet Corporation and Stockholders (November 20, 2015)
Registration Rights Agreements
Egalet Corp
Pharmaceuticals
DE
2015
Controlled Equity Offering Sales Agreement between Egalet Corporation and Cantor Fitzgerald & Co. dated July 2, 2015
Equity Distribution Agreements
Egalet Corp
Pharmaceuticals
NY
2015
Indenture Agreement for 5.50% Convertible Senior Notes due 2020 between Egalet Corporation and The Bank of New York Mellon
Indenture Agreements
Egalet Corp
Pharmaceuticals
NY
2015
Egalet Corporation $60,000,000 5.50% Convertible Senior Notes Due 2020 Purchase Agreement with JMP Securities LLC and Guggenheim Securities, LLC
Purchase Agreements
Egalet Corp
Pharmaceuticals
NY
2015
Asset Purchase Agreement between Luitpold Pharmaceuticals, Inc. and Egalet US, Inc. (with Egalet Corporation Guarantee)
Purchase Agreements
Egalet Corp
Pharmaceuticals
DE
2015
Common Stock Purchase Agreement between Egalet Corporation and Shionogi Limited (November 26, 2013)
Purchase Agreements
Egalet Corp
Pharmaceuticals
NY
2013
Egalet Corporation Restricted Stock Award Agreement with Grantee (November 2013)
Equity Distribution Agreements
Egalet Corp
Pharmaceuticals
DE
2013